CEL-SCI Corporation news

   Watch this stock
Showing stories 1 - 10 of about 33   

Articles published

CVM 1.87 +0.08 (4.47%)
price chart
CEL-SCI Corporation (CVM): Analyzing CEO Compensation
Geert Kersten took the reins as CEL-SCI Corporation's (AMEX:CVM) CEO and earned a total compensation of $629,313 over the past year.
This Weeks Target Prices For Cel-Sci Corporation (CVM)  NewsDen
CEL-SCI Announces $1.5 Million NIH SBIR Grant to Support Development of ...
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) announced today that it has been awarded a new Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Arthritis and Musculoskeletal and Skin ...
Kura Oncology, Inc. (KURA) has a value of $12.50 per share While CEL-SCI ...  Stocks Gallery
Blackrock Inc. is the third biggest owner of CEL-SCI Corporation (CVM)
CEL-SCI Corporation (NYSE:CVM) enjoyed a 18.49% run-up in share price since hitting record low of $1.46. The stock managed 4.85% rise and now stands at $1.73 as of September 22, 2017.
CEL-SCI Corporation (CVM) is at $1.60 per share and Cidara Therapeutics, Inc ...
In recent trading day CEL-SCI Corporation (CVM) stock showed the move of -4.19% with the closing price of $1.60. Closing price generally refers to the last price at which a stock trades during a regular trading session.
CEL-SCI Corporation (CVM) stock RSI moves to 29.02
CEL-SCI Corporation (CVM) stock go down so far this year; showing a decline of -5.36% and dropped with negative flow of -10.17% during recent week.
Could Cel Sci Corporation (NYSEMKT:CVM) Skyrocket? The Stock Had Too Little ...
The stock of Cel Sci Corporation (NYSEMKT:CVM) registered a decrease of 17.07% in short interest. CVM's total short interest was 628,800 shares in September as published by FINRA.
NIH Awards $1.5M Grant to Help Develop Rheumatoid Arthritis Vaccine
CEL-SCI Corporation announced that it has been awarded a new Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases entitled “Preclinical studies of PG70 LEAPS peptide ...
CEL-SCI Corporation (CVM) Stock Recap
In terms of CEL-SCI Corporation (CVM) stock price comparison to its moving averages, shares of company are -24.29% away from the 50-day moving average and -17.54% away from 20-day average.
CEL-SCI CORP. NEW DL-,01 (LSRM) Declined -2.74% on Sep 30
Shares of CEL-SCI CORP. NEW DL-,01 (FRA:LSRM) last traded at 1.35, representing a move of -2.74%, or -0.04 per share, on volume of shares.
West Nile Virus Infections – Market Analysis, H2 2017 Key Players Mentioned ...
A new research document with title 'West Nile Virus Infections - Pipeline Review, H2 2017' covering detailed analysis, Competitive landscape, forecast and strategies.